Healthcare Investors Dedicated to Partnering with Exceptional Companies

Our mission is to unite our industry expertise and capital with entrepreneurs and management teams to deliver successful results and improve the lives of patients.

Strategy:

Ellie Diagnostics

https://elliediagnostics.com/

Investment Date: 2021

Read more
Antios Therapeutics

https://www.antiostherapeutics.com/

Investment Date: 2021

Read more
Jasper Therapeutics

https://www.jaspertherapeutics.com/

Investment Date: 2021

Read more
Caribou Biosciences

https://www.cariboubio.com/

Investment Date: 2021

Read more
Ribon Therapeutics

https://ribontx.com/

Investment Date: 2021

Read more
Arch Oncology

https://archoncology.com/

Investment Date: 2021

Read more
Immunocore

https://www.immunocore.com/

Investment Date: 2020

Read more
Sentynl Therapeutics

http://www.sentynl.com/

Investment Date: 2015

Read more
Amber Ophthalmics

Investment Date: 2020

Read more
Eyevance Pharmaceuticals

https://eyevance.com/

Investment Date: 2017

Read more
Sebela Pharmaceuticals

https://sebelapharma.com/

Investment Date: 2018

Read more
Saol Therapeutics

https://saolrx.com/

Investment Date: 2015

Read more

Ellie Diagnostics

https://elliediagnostics.com/

Investment Date: 2021

Disruptive animal health provider delivering innovative diagnostic solutions to veterinarians and pet owners across the United States.

Antios Therapeutics

https://www.antiostherapeutics.com/

Investment Date: 2021

Clinical-stage biotechnology company developing innovative therapies to treat and cure chronic hepatitis B virus (HBV).

Jasper Therapeutics

https://www.jaspertherapeutics.com/

Investment Date: 2021

Clinical-stage biotechnology company focused on enabling cures with hematopoietic stem cell therapies.

Merged with Amplitude Healthcare Acquisition Corporation in 2021

Caribou Biosciences

https://www.cariboubio.com/

Investment Date: 2021

Clinical-stage biotechnology company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases.

Completed IPO in 2021

Ribon Therapeutics

https://ribontx.com/

Investment Date: 2021

Clinical-stage biotechnology company pursuing the development of novel small molecules that target cancer through its dependency on stress support pathways.

Arch Oncology

https://archoncology.com/

Investment Date: 2021

Clinical-stage immuno-oncology company that aims to discover and develop potential best-in-class antibody therapies for the treatment of patients with cancer.

Immunocore

https://www.immunocore.com/

Investment Date: 2020

Clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease.

Completed IPO in 2021

Sentynl Therapeutics

http://www.sentynl.com/

Investment Date: 2015

Commercial-stage specialty pharmaceutical company focused on pain management and adjacent specialty therapeutics areas.

Acquired by Zydus in 2017

Amber Ophthalmics

Investment Date: 2020

Clinical-stage ophthalmic company focused on novel therapeutics to address unmet medical needs, providing for the restoration, preservation, and improvement of patient vision and quality of life.

Eyevance Pharmaceuticals

https://eyevance.com/

Investment Date: 2017

Commercial-stage specialty ophthalmic company focused on innovative and impactful branded prescription products targeting the anterior segment of the eye.

Acquired by Santen in 2020

Sebela Pharmaceuticals

https://sebelapharma.com/

Investment Date: 2018

Commercial-stage specialty pharmaceutical company focused on gastrointestinal, dermatological, and women’s health products.

Saol Therapeutics

https://saolrx.com/

Investment Date: 2015

Commercial-stage specialty pharmaceutical company focused on the central nervous system (CNS), orphan diseases, and conditions with high unmet medical need.